Evidence map›Paper›PMID 23085241›Full record

ArticleCellular immunology2012

E3 ubiquitin ligase NKLAM is a macrophage phagosome protein and plays a role in bacterial killing.

Donald W Lawrence, Jacki Kornbluth

Abstract read
In one paragraph

Article in Cellular immunology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Donald W LawrenceDepartment of Pathology, Saint Louis University School of Medicine, St. Louis, MO 63104, United States.
Jacki Kornbluth
Saint Louis University · US

Funding

Role of Natural Killer Lytic-Associated Molecule (NKLAM) in Natural Killer FunctiR56AI089758 · NIAID · SAINT LOUIS UNIVERSITY · PI KORNBLUTH, JACKI · 2010 to 2010
$338k
NKLAM: An RBR E3 Ubiquitin Ligase Essential for Regulation of Innate ImmunityI01BX000705 · VA · ST. LOUIS VA MEDICAL CENTER · PI KORNBLUTH, JACKI · 2012 to 2020
–
BLRD VA I01 BX000705NIAID NIH HHS R56 AI089758NIAID NIH HHS R56AI089758
6 · The paper itself

Abstract

Macrophages are a critically important component of the innate and adaptive immune systems. They are equipped with oxidative and non-oxidative mechanisms to kill ingested pathogens. Natural Killer Lytic-Associated Molecule (NKLAM) is an E3 ubiquitin ligase expressed in macrophages and natural killer cells. We show that NKLAM expression in macrophages was enhanced by Toll-like receptor agonists and pro-inflammatory cytokines. Using confocal microscopy, we found that NKLAM colocalized with ingested Escherichia coli. In assays using IgG-opsonized latex beads as targets, we demonstrated that NKLAM translocated to the phagosome early during maturation at a time that coincided with elevated levels of ubiquitinated phagosome proteins. In killing assays with bone marrow-derived macrophages from wild type and NKLAM-deficient mice, we found that NKLAM-deficient macrophages demonstrated less killing of E. coli than wild type macrophages. Collectively, our data show that NKLAM is a novel component of macrophage phagosomes and is involved in macrophage bactericidal functions.

Indexed as

AnimalsBlotting, WesternCell LineEscherichia coliFlow CytometryHost-Pathogen InteractionsLipopolysaccharidesMacrophagesMembrane ProteinsMiceMice, Inbred C57BLMice, KnockoutMicroscopy, ConfocalPhagocytosisPhagosomesToll-Like Receptor 4LipopolysaccharidesMembrane ProteinsNK lytic-associated moleculeToll-Like Receptor 4Ubiquitin-Protein Ligases

Identifiers

PMID23085241
PMCPMC3518603
OpenAlexW2090105869

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.